TTRX stock news · Turn Therapeutics Inc
Get alerts for TTRX
Follow Turn Therapeutics Inc (TTRX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TTRXAn analyst at Ares Management starts with a positive outlook and shares the top 5 picks for Thursday.
Good for TTRXTurn Therapeutics had Lucid Capital Markets begin coverage with a Buy rating and a $24 target, which signals stronger analyst support for the stock.
12 health care stocks changed a lot during Friday's after-hours trading.
Bad for TTRXTurn Therapeutics stock declined 6.86% to $11.82 after hours, a downward move for Turn.
Turn Therapeutics Inc. shared important news and financial details with the SEC.
NeutralTurn Therapeutics filed a Form 8-K furnishing a press release; the filing contains no operational or financial detail, so I read it as neutral for the company.
Turn Therapeutics Inc. tells the SEC about important information for investors.
NeutralTurn Therapeutics filed an 8-K furnishing a press release but offered no new business or financial details, so the filing itself does not change the company's outlook.
On Tuesday, 12 health care stocks saw big price changes during the day.
Good for TTRXTurn Therapeutics rose 25.61% to $12.31, reflecting notable investor demand in that trading session.